Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Urinary Bladder Matrix (UBM) Registry

NCT: NCT07805798 · NOT_YET_RECRUITING

NCT IDNCT07805798
StatusNOT_YET_RECRUITING
Start Date2026-08-31
Completion2029-12-31
SponsorIntegra LifeSciences Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this registry is to collect real-world information on patients treated with Urinary Bladder Matrix (UBM) products. The study will evaluate patient characteristics, treatment patterns, and clinical outcomes to better understand how UBM products are used in routine clinical practice and the outcomes experienced by patients over time.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑